Proteomics in Multiple Trauma to Identify Organ Failure

NCT02030327 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2022-05-17

No results posted yet for this study

Summary

To analyse differences in protein expression in multiple trauma patients for identification of potential biomarkers to predict organ dysfunction.

Conditions

  • Multiple Trauma

Sponsors & Collaborators

  • Universitätsklinikum Köln

    lead OTHER

Principal Investigators

  • Jochen Hinkelbein, MD · UK Köln

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02030327 on ClinicalTrials.gov